EFGARTIGIMOD ALFA Pharmacologic Class Indexing
- Class set ID
- bcfc634d-51ba-45f8-a489-d9933a9e94c2
- Version
- 1
- Effective date
- 20230404
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use VYVGART HYTRULO safely and effectively. See full prescribing information for VYVGART HYTRULO. VYVGART HYTRULO ® (efgartigimod alfa and hyaluronidase-qvfc) injection, for subcutaneous use Initial U.S. Approval: 2023 | argenx US | Patheon Italia SpA | Avid Bioservices Inc. | Vetter RVS | Lonza Biologics Portsmouth | Catalent Indiana, LLC | 20260513 | 12 |
| These highlights do not include all the information needed to use VYVGART safely and effectively. See full prescribing information for VYVGART. VYVGART ® (efgartigimod alfa-fcab) injection, for intravenous use Initial U.S. Approval: 2021 | argenx US | Vetter Mooswiesen | Patheon Italia SpA | Lonza Biologics Portsmouth | 20260513 | 15 |